RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Haba Laboratories Stock

Haba Laboratories Liabilities 2024

Haba Laboratories Liabilities

3.92 B JPY

Ticker

4925.T

ISIN

JP3765130004

In 2024, Haba Laboratories's total liabilities amounted to 3.92 B JPY, a -3.06% difference from the 4.05 B JPY total liabilities in the previous year.

Haba Laboratories Aktienanalyse

What does Haba Laboratories do?

Haba Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Haba Laboratories's Liabilities

Haba Laboratories's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Haba Laboratories's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Haba Laboratories's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Haba Laboratories's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Haba Laboratories’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Haba Laboratories stock

What is the level of liabilities of Haba Laboratories this year?

Haba Laboratories has a debt balance of 3.92 B JPY this year.

What were the liabilities of Haba Laboratories compared to the previous year?

The liabilities of Haba Laboratories have increased by -3.06% dropped compared to the previous year.

What are the consequences of high debt for investors of Haba Laboratories?

High liabilities can pose a risk for investors of Haba Laboratories, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Haba Laboratories?

Low liabilities mean that Haba Laboratories has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Haba Laboratories affect the company?

An increase in liabilities of Haba Laboratories can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Haba Laboratories affect the company?

A decrease in the liabilities of Haba Laboratories can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Haba Laboratories?

Some factors that can influence the liabilities of Haba Laboratories include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Haba Laboratories so important for investors?

The liabilities of Haba Laboratories are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Haba Laboratories take to modify the liabilities?

To change its liabilities, Haba Laboratories can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Haba Laboratories pay?

Over the past 12 months, Haba Laboratories paid a dividend of 40 JPY . This corresponds to a dividend yield of about 2.51 %. For the coming 12 months, Haba Laboratories is expected to pay a dividend of 40 JPY.

What is the dividend yield of Haba Laboratories?

The current dividend yield of Haba Laboratories is 2.51 %.

When does Haba Laboratories pay dividends?

Haba Laboratories pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Haba Laboratories?

Haba Laboratories paid dividends every year for the past 20 years.

What is the dividend of Haba Laboratories?

For the upcoming 12 months, dividends amounting to 40 JPY are expected. This corresponds to a dividend yield of 2.51 %.

In which sector is Haba Laboratories located?

Haba Laboratories is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Haba Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Haba Laboratories from 6/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Haba Laboratories pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Haba Laboratories in the year 2023?

In the year 2023, Haba Laboratories distributed 40 JPY as dividends.

In which currency does Haba Laboratories pay out the dividend?

The dividends of Haba Laboratories are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Haba Laboratories

Our stock analysis for Haba Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Haba Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.